Vistagen Therapeutics Inc (VTGN)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
2.22 -0.12 (-5.13%) 04/25/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 2.24 +0.02 (+0.90%) 19:52 ET
for Fri, Apr 25th, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 03-2024 | 03-2023 | 03-2022 | 03-2021 | 03-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -29,362 | -59,248 | -47,762 | -17,934 | -20,774 |
| Depreciation Amortization | 127 | 130 | 154 | 118 | 117 |
| Accounts receivable | N/A | N/A | N/A | N/A | 300 |
| Other Working Capital | 1,288 | 2,460 | -1,241 | 3,391 | 92 |
| Other Operating Activity | 2,134 | 6,942 | 3,593 | 2,353 | 4,508 |
| Operating Cash Flow | $-25,813 | $-49,716 | $-45,257 | $-12,074 | $-15,757 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -61 | -212 | -200 | -275 | N/A |
| Net Acquisitions | N/A | -528 | N/A | N/A | N/A |
| Investing Cash Flow | $-61 | $-740 | $-200 | $-275 | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | N/A | 300 |
| Debt Issued | N/A | N/A | N/A | 224 | N/A |
| Debt Repayment | -985 | -1,034 | -3 | -606 | -297 |
| Common Stock Issued | 35,934 | -7 | 10,487 | 20,809 | 4,008 |
| Other Financing Activity | 93,453 | 0 | 0 | 93,675 | 0 |
| Financing Cash Flow | $128,402 | $-1,041 | $10,484 | $114,102 | $4,012 |
| Beginning Cash Position | 16,638 | 68,135 | 103,108 | 1,355 | 13,100 |
| End Cash Position | 119,166 | 16,638 | 68,135 | 103,108 | 1,355 |
| Net Cash Flow | $102,528 | $-51,497 | $-34,973 | $101,753 | $-11,745 |
| Free Cash Flow | |||||
| Operating Cash Flow | -25,813 | -49,716 | -45,257 | -12,074 | -15,757 |
| Capital Expenditure | -61 | -212 | -200 | -275 | N/A |
| Free Cash Flow | -25,874 | -49,928 | -45,457 | -12,349 | -15,757 |